2014;9(1):e85397
Moving forward, the results of the phase 3 SURPASS clinical trial program demonstrated that tirzepatide was as effective and safe as other anti-diabetic agents, such as semaglutide and dulaglutide (SURPASS-2) (SURPASS J-mono), long-acting insulin analogs (degludec and glargine) (SURPASS-3,4), and placebo (SURPASS-1) (SURPASS-5), in managing T2DM diabetes [65,66,67,68,69]
Wegovy is also FDA-approved for cardiovascular risk reduction in adults with established cardiovascular disease and obesity or overweight, and for chronic weight management in pediatric patients aged 12 years and older with obesity
The Princeton IV Consensus provides guidance on risk stratification and evaluation
This cycle ensures hair balance and constant regeneration, varying according to individual characteristics and influenced by factors like hormones and nutrients